4//SEC Filing
Ludwig Jeffrey Jerome 4
Accession 0001437749-23-019523
CIK 0001401667other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 7:08 PM ET
Size
5.1 KB
Accession
0001437749-23-019523
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-07-03$3.31/sh−12,103$40,075→ 112,926 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.24 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001807133
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 7:08 PM ET
- Size
- 5.1 KB